Catalent buys new filling tech for DPI drugs

- Last updated on GMT

US CMO Catalent says the purchase of Harro Hofiger Omnidose filling unit makes it a “one stop shop” for development of inhalable drugs.

The unit, which will be installed at the contract manufacturing organisations (CMOs) facility in North Carolina, enables powder filling in the 1 to 300mg into any currently available dry powder inhalation (DPI) on the market.

Catalent said that the technology will support its range of contract manufacturing services for clinical trial supplies for Phase I and II trials and provide “a scaleable path to higher volume late stage clinical and commercial manufacturing.”

The New Jersey, headquartered firm also said that the technology compliments its existing pressurised metered-dose inhaler (pMDI) inhaler manufacturing capacity.

Related news

Show more

Related products

show more

Flexible Filling Solution for CMOs

Flexible Filling Solution for CMOs

Single Use Support GmBH | 18-May-2022 | Insight Guide

Achieving flexibility requires modularity of technologies.

CMOs and CDMOs aspire to be flexible for multiple applications. Efficient automated...

Eastern & Western Manufacturing Solutions

Eastern & Western Manufacturing Solutions

Piramal Pharma Solutions | 15-Mar-2022 | Technical / White Paper

The best manufacturing site for a product can change throughout the life cycle. When bringing new drugs to market, biopharma companies may benefit from...

Related suppliers

Follow us

Products

View more

Webinars